Press Releases
2018 Lupus Insight Prize Presented to Dr. Betty Diamond

2018 Lupus Insight Prize Presented to Dr. Betty Diamond Funds Study of Common Hypertension Drugs to Treat Lupus San Francisco, CA. June 21, 2018. The Lupus Research Alliance has awarded its 2018 Lupus Insight Prize to Betty Diamond, MD, for a project to test commonly used drugs for high blood pressure as potential treatments for […] READ MORE

2018 Omnibus Budget Passed March 23 Grants Lupus Advocates’ Requests

March 23, 2018 The Omnibus Appropriations bill for Fiscal Year 2018 that passed today includes key provisions the Lupus Research Alliance and lupus advocates have worked for all year. Lupus advocates, participating just days before for our annual March Capitol Hill Day, had requested program funding for 2019 and had asked legislators to also finish […] READ MORE

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH program to accelerate therapies for arthritis, lupus releases first datasets Collaborative effort provides important clues about potential research targets NEW YORK, NY. Feb. 21, 2018.  Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the Accelerating Medicines Partnership for Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Phase I […] READ MORE

Lupus Research Alliance Announces New Grants For Translational Research

        Lupus Research Alliance Announces New Grants for Translational Research Seven Outstanding Investigators Chosen for Prestigious Lupus Research Grants Jan. 10, 2018. The Lupus Research Alliance is proud to announce the recipients of its Target Identification in Lupus (TIL) grants designed to move research discoveries quickly from the laboratory to the patient’s […] READ MORE

Lupus Multi-Cultural Engagement Partnership

  The Lupus Research Alliance and the National Minority Quality Forum Announce Lupus Multi-Cultural Engagement Partnership NEW YORK, December 19, 2017 — The Lupus Research Alliance and the National Minority Quality Forum launched the Lupus Multi-Cultural Engagement Partnership at the recent inaugural meeting in New York City which was attended by 30 national experts and key […] READ MORE

Lupus Research Alliance’s Breaking Through Gala

Lupus Research Alliance Welcomes Steve Burke, Selena Gomez, Seth Meyers and Kelli O’Hara to Breaking through Lupus Gala Raises Over $3.2 Million for Lupus Research November 21, 2017 – New York, NY – The Lupus Research Alliance celebrated the 2017 Breaking through Lupus Gala to shed a spotlight on breakthroughs from the previous years, and […] READ MORE

Lupus Research Alliance Prompted Stelara® Study for Lupus

Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medicine from the Janssen Pharmaceutical Companies. Stelara® is not approved for the treatment of lupus, but is approved by the FDA for certain autoimmune diseases. Through its drug repurposing program, the Lupus Research Alliance first identified Stelara® as a potential treatment for lupus and encouraged Janssen to pursue testing for this use. READ MORE

Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […] READ MORE

Lupus Research Alliance Welcomes Self-Injectable Form of Belimumab

The Lupus Research Alliance congratulates GlaxoSmithKline (GSK) on the approval of belimumab (Benlysta®) by the U.S. Food and Drug Administration as a self-injectable (subcutaneous) formulation for people with systemic lupus erythematosus being treated with standard therapy. Belimumab is currently approved as a one-hour intravenous infusion given once every four weeks by a healthcare professional in […] READ MORE

Large Multi-ethnic Study Identifies Many New Genetic Markers for Lupus

Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus. The study is published in the July 17 issue of the journal Nature Communications and was led by researchers at Wake Forest Baptist Medical Center, Oklahoma Medical Research Foundation, King’s College of London and Genentech Inc. Autoimmune diseases […] READ MORE

Learn and connect with our community!